Jounce Therapeutics, Inc.

MORGAN STANLEY

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

119,925

Value ($000)

222

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	222	0.0%	119,925	3/31/2023
2022 Q4	2/14/2023	1,840	0.0%	1,657,925	12/31/2022
2022 Q3	11/14/2022	3,928	0.0%	1,678,448	9/30/2022
2022 Q2	10/27/2022	4,937	0.0%	1,629,922	6/30/2022
2022 Q1	10/27/2022	10,363	0.0%	1,526,288	3/31/2022
2021 Q4	2/14/2022	295	0.0%	35,393	12/31/2021
2021 Q3	11/15/2021	175	0.0%	23,705	9/30/2021
2021 Q2	8/23/2021	617	0.0%	90,731	6/30/2021
2021 Q1	5/17/2021	174	0.0%	16,956	3/31/2021
2020 Q4	2/16/2021	243	0.0%	34,729	12/31/2020
2020 Q3	11/13/2020	278	0.0%	33,999	9/30/2020
2020 Q2	8/14/2020	168	0.0%	24,328	6/30/2020
2020 Q1	5/26/2020	210	0.0%	44,258	3/31/2020
2019 Q4	2/14/2020	414	0.0%	47,360	12/31/2019